Immatics IMTX
NASDAQ IMTX
$9.56 +0.10 (+1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immatics (IMTX) Change in Accured Expenses (2019 - 2026)

Immatics (IMTX) posted Change in Accured Expenses of -$34.4 million for Q1 2024, down 303.35% sequentially from $16.9 million in Q4 2023, and down 311.37% YoY from $16.3 million in Q2 2023.

Analysis

Immatics (IMTX) Change in Accured Expenses (2019 - 2026) Analysis & Trends

Immatics has reported Change in Accured Expenses for 6 years, with the latest figure at -$34.4 million in Q1 2024.

  • Quarterly Change in Accured Expenses fell 311.37% year-over-year to -$34.4 million in Q1 2024, while the trailing twelve-month figure through Mar 2024 was -$26.0 million (down 433.43% YoY) and the FY2025 annual result came in at -$42.5 million, up 73.78% from the prior year.
  • Change in Accured Expenses fell to -$34.4 million in Q1 2024 per IMTX's latest filing, from $16.9 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $68.4 million in Q2 2022 and troughed at -$39.4 million in Q4 2022.
  • A 5-year average of -$2.3 million and a median of -$7.4 million in 2020 frame the typical range for Change in Accured Expenses.
  • The sharpest annual moves came in 2022 and 2024: Change in Accured Expenses jumped 1304.44% in 2022, then slumped 311.37% in 2024.
  • Over 5 years, Change in Accured Expenses stood at -$8.8 million in 2020, then tumbled by 128.77% to -$20.1 million in 2021, then plunged by 96.28% to -$39.4 million in 2022, then surged by 142.94% to $16.9 million in 2023, then slumped by 303.35% to -$34.4 million in 2024.
  • According to Business Quant data, Change in Accured Expenses over the past three periods registered -$34.4 million, $16.9 million, and -$6.3 million for Q1 2024, Q4 2023, and Q3 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 55.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 212.44 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 61.62 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 68.82 Mn
10 Immatics 1.17 Bn 711.21 Mn - -609,077.61
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -609,077.61
Mar 31, 2026 12.18 Mn
Dec 31, 2025 -44.63 Mn
Sep 30, 2025 19.01 Mn
Jun 30, 2025 551,264.37
Mar 31, 2025 -16.85 Mn
Dec 31, 2024 -160.71 Mn
Sep 30, 2024 256,983.36
Jun 30, 2024 243,376.59
Mar 31, 2024 210,754.18
Dec 31, 2023 91.86 Mn
Sep 30, 2023 238,401.31
Jun 30, 2023 8.92 Mn
Mar 31, 2023 -8.36 Mn
Dec 31, 2022 -39.41 Mn
Sep 30, 2022 -12.85 Mn
Jun 30, 2022 68.43 Mn
Mar 31, 2022 36.81 Mn
Dec 31, 2021 -20.08 Mn
Sep 30, 2021 -3.38 Mn